Fig. 9From: Afrormosin exerts an anticancer effect via MAPK and AKT signaling pathways in B16F10 cellsThe effect of afrormosin on MAPK and PI3K/AKT pathways in B16F10 cells. Afrormosin could inhibit the phosphorylation of ERK and AKT to reduce cell proliferation, but it could increase the phosphorylation of p38 and JNK to induce apoptosis. Red lines: MAPK signaling. Blue lines: AKT signaling.Back to article page